NICA: Nanologica AB (publ) - Summary | Jitta

Nanologica AB (publ)

SWE:NICA

Price
kr0.66
Loss Chance
54.1%
2.04JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
26 / 107
252 / 616
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (53)
Recent Business Performance (84)
Financial Strength (37)
Return to Shareholders (13)
Competitive Advantage (43)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.04
100.00%
2.24
119.80%
2.89
152.39%
Biotechnology
2.69
100.00%
2.77
100.00%
6.92
400.08%
COMPANY DESCRIPTION
Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; NLAB Idun is an agarose-based purification media for ion exchange chromatography; NLAB Siv is a non-silica-based purification media used in preparative chromatography; analytical chromatography is used as an analysis method in the pharmaceutical and food industries; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces; . The company also provides peptides drugs such as insulin and GLP-1 analogues for the treatment of diabetes and obesity. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.